DGS Capital Management, LLC

Source: SEC Form 13F · as of Mar 2026

DGS Capital Management, LLC holds 46 biotech & pharma companies tracked by BioSniper, totaling $39.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

46

Total value held

$39.2M

CompanySharesValue
JNJJOHNSON & JOHNSON13,631$3.3M
IDXXIDEXX LABORATORIES INC /DE5,750$3.2M
NVSNovartis AG21,135$3.2M
LLYELI LILLY & Co3,475$3.2M
GMOptec International, Inc.39,268$2.9M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)42,695$2.4M
GILDGILEAD SCIENCES, INC.14,029$2.0M
MRKMerck & Co., Inc.14,018$1.7M
ABBVAbbVie Inc.6,748$1.5M
HLFHerbalife Ltd.82,323$1.2M
NVONovo Nordisk A/S31,948$1.2M
PMPhilip Morris International Inc6,813$1.1M
AMGNAMGEN INC2,595$913K
ELVElevance Health Inc.2,980$872K
RDYDR REDDYS LABORATORIES LTD52,937$733K
INCYIncyte Corp.6,682$629K
UTHRUNITED THERAPEUTICS Corp1,034$613K
BMYBRISTOL MYERS SQUIBB CO9,857$598K
VRTXVERTEX PHARMACEUTICALS INC / MA1,310$585K
BIIBBIOGEN INC.2,886$529K
SNYSanofi10,737$517K
UNHUnitedHealth Group Incorporated Common Stock (DE)1,892$512K
CORCencora Inc.1,579$496K
MCKMcKesson Corporation536$464K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)23,106$428K
TEVATeva Pharmaceutical Industries Limited10,945$330K
REGNREGENERON PHARMACEUTICALS, INC.415$321K
CAHCardinal Health Inc.1,425$301K
JAZZJazz Pharmaceuticals plc1,536$290K
ABTABBOTT LABORATORIES2,688$276K
OSCROscar Health Inc.23,902$274K
GMABGenmab A/S10,173$273K
NUSNu Skin Enterprises Inc.36,144$263K
RPRXRoyalty Pharma plc5,417$260K
AZNASTRAZENECA PLC1,276$252K
PFEPFIZER INC8,128$228K
SIGASIGA TECHNOLOGIES INC42,434$227K
GEHCGE HealthCare Technologies Inc.3,087$220K
USNAUSANA HEALTH SCIENCES INC11,899$208K
NRCNational Research Corporation Common Stock (Delaware)10,371$176K
VTRSViatris Inc12,475$169K
ZVRAZEVRA THERAPEUTICS, INC.14,810$138K
PBYIPUMA BIOTECHNOLOGY, INC.10,418$67K
IRWDIRONWOOD PHARMACEUTICALS INC14,883$52K
LFVNLifevantage Corp10,168$44K
IVVDInvivyd, Inc.11,300$15K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    DGS Capital Management, LLC — Biotech 13F Holdings & Portfolio | BioSniper